OBJECTIVES: The management of chest tubes is one of the most critical aspects in patient care in thoracic surgery, and no consensus exists regarding the ideal chest tube management strategy.
INTRODUCTION
Standardization of medical treatment through broad consensus and diffusion of medical treatment is desirable for several reasons: (i) It sets the basis for a continuous re-evaluation and directed improvement of medical therapy, (ii) it facilitates the training of surgeons, doctors and expert medical staff and (iii) it allows benchmarking and cost analysis on the level of healthcare providers, health insurers and society (Health Service Research, Health Technology Assessment). In oncologic thoracic surgery, generally accepted guidelines exist for diagnostic procedures, indications for surgery and integration of different treatment modalities [1] [2] [3] . However, the perioperative treatment of patients lacks published evidence and relies mostly on individual decision making [4] . Here, the duration of postoperative chest tube (ChT) management has been identified as a central step towards postoperative recovery and as a limiting factor for hospital discharge. So far, no generally accepted recommendations exist for postoperative ChT management to streamline the postoperative stay [5] [6] [7] . Recent 'fast-track' surgery approaches are geared towards the reduction of treatment-related costs by shortening it [7, 8] .
Until recently, the decision as to when to remove a ChT depended on the assessment of air bubbles in analogue drainage systems [9] . This approach does not afford quantification of detected air leaks and always includes some degree of subjectivity and uncertainty. The latter results in the application of different ChT management protocols and variable 'safety corridors' before a ChT is finally removed.
With the introduction of digital drainage systems by several companies, the presence of an air leak ( justifying the continuation of ChT therapy) is now objectively definable and quantifiable [9] . The first studies applying digital chest drainage systems have reported a reduction in inter-observer variability [10] and treatment durations [5, 11, 12] . It can therefore be assumed that the growing experience with digital chest drainage systems will result in a reduction of the unintentionally applied 'safety corridors'. However, since the applied ChT management protocols differ in various parameters, it is unlikely that this effect will translate directly to patient discharge.
Being interested in the variation in ChT management across centres and its effect on postoperative length of stay, we conducted a prospective clinical analysis at four major thoracic surgery units. To obtain a non-biased assessment of the presence of an air leak warranting continued ChT therapy, a digital air leak metre was used.
MATERIALS AND METHODS

Study design
A prospective multicentric case series was performed. The study was authorized by the responsible ethics committees of Land Bremen (KBB/mh), Landesärztekammer Baden-Württemberg (2009-042-f), Landesärztekammer Rheinland-Pfalz and Ärztekam-mer Berlin and registered at an independent international clinical trial registry (NCT01467622) [13] . Our primary study objective was the duration of ChT therapy in postoperative patients and postoperative hospital stay.
Patient cohort
Between April and August 2009, patients undergoing pulmonary wedge resection, anatomic segmentectomy or lobectomy were prospectively enrolled at four German thoracic surgery specialist units [Klinikum Bremen Ost (KBO), Bremen; Klinik Schillerhoehe (KSH), Gerlingen; Katholisches Klinikum (KKK), Koblenz; Evangelische Lungenklinik Berlin (ELK), Berlin] (Fig. 1 ). Inclusion criteria were: age 18-85, pulmonary wedge resection, anatomic segmentectomy or lobectomy with informed consent. Exclusion criteria were: spontaneous pneumothorax ( primary and secondary), pleural empyema, medication with corticoids, immunosuppressive drugs or platelet aggregation inhibitors other than Aspirin, previous chemotherapy, previous radiotherapy of the chest and previous ipsilateral thoracic surgery. The following data were collected for analysis: demographical patient data, indication for surgery, surgery performed, presence and extent of air leak, drained fluid volume, day of ChT removal and length of hospital stay.
Pulmonary air leak assessment
For application of variable external suction [9] , the digital pleural drainage system Thopaz™ (Medela, Baar, Switzerland) was used in all patients. The system indicates, in real time, measured air flow (in the ChT) and effective negative pressure in the pleural cavity (as measured at the end of the ChT). The presence of an air leakage was defined by an air flow larger than 10 ml/min. The detected time of an air leakage was defined as the duration from the onset of the device until the absence of the air leakage for at least 4 h.
Chest tube management protocols
Every centre applied its own established treatment protocol for ChT management. This was defined by: (i) applied minimum and maximum negative pressure, (ii) cut-off for maximal fluid efflux per day, (iii) duration of the safety interval following detected air leakage cessation (Table 1) . Patients with more than one ChT were followed until the last tube was removed. No provocative clamping of the ChT ( prior to tube removal) was permitted. 
Data analysis
Statistical analysis was performed using SAS ® (version 9.2). Fisher's exact test for categorical data was applied to test for homogeneity and to compare the relative frequency of events between groups. Groups of continuous data were compared by Wilcoxon's test with continuity correction and the Kruskal-Wallis test respectively. Analysis of drainage time was conducted using Kaplan-Meier estimates and the log-rank test. Spearman's rank correlation coefficient (Spearman's ρ) was used to test for statistical dependence. All P-values were two-sided, and a P-value of <0.05 was considered to indicate statistical significance.
RESULTS
Study population
Overall, 80 patients were enrolled. One patient had to be excluded due to damage of the respective digital Thopaz™ log-file ( Table 1) . The majority of patients were male (67%) aged 64.0 ± 10.3 years (range 41-85). Lung resections were performed due to primary lung cancer or secondary metastasis to the lung in 94% of cases. The other indications were pulmonary bulla (n = 1), mediastinal tumour (n = 1), mesenchymal pleural tumour (n = 1) and interstitial lung disease (n = 2). Collectively, 30 wedge resections, 14 segmentectomies and 35 lobectomies were performed (Fig. 1) .
Chest tube management protocols
While the definition and the assessment of a pulmonary air leak were identical in all thoracic surgery units, the resulting course of action for removing the ChT varied in several aspects: There were no uniform suction levels, different tolerated drainage volumes (on day of ChT removal), and varied follow-up periods to ensure absence of air leakages (Table 1) .
Effects on chest tube therapy
The overall air leak duration (as detected by the Thopaz™ device) was 1.61 ± 1.58 days without significant differences between centres (P = 0.1464) ( Table 1) . However, the resulting period of ChT therapy was on average 4.9 ± 2.8 days. Analysed according to individual participating centres, there was a significant degree of scatter from 3.59 ± 1.87 to 5.48 ± 3.18 days (P = 0.0348) (Fig. 2) . The delay in ChT removal after air leakage closure was more than 3 days and varied significantly between centres from 1.86 to 4.23 days (P = 0.0051). Regarding the type of resection, wedge resections and segementectomies required shorter ChT durations than lobectomies (4.03 ± 2.68 and 4.07 ± 1.63 days vs 5.97 ± 2.96 days, P = 0.0109) (Fig. 2B) . In this study, a higher initial suction level (4.0 kPa) was associated with earlier postoperative air leakage closure and resulted in shorter ChT duration (4.18 ± 2.35 days vs 5.41 ± 3.01 days, P = 0.058) (Fig. 2C) . Most ChT were removed during the weekend rather than during the beginning of the week, peaking on Fridays (Fig. 2D) .
Effects on hospital stay
Following ChT removal, patient discharge from hospital was delayed on average by 3.16 ± 2.88 days, ranging from 2.23 ± 2.05 to 4.09 ± 3.45 days (P = 0.0057) ( Table 1) . Surprisingly, the finding of different ChT removal rates in the participating centres did not translate into similar differences in the length of hospital stay (average 7.7 ± 3.7 days; range, 7.2 ± 3.1-10.8 ± 3.1 days; P = 0.3790) (Fig. 3) . The delay in hospital release was not correlated with the previous duration of ChT therapy (Spearman's ρ = −0.1457, P = 0.2544). Similarly, duration of ChT therapy was not influenced by the postoperative suction (negative pressure) level (P = 0.5375) (Fig. 3B) ; however, the total hospital stay was significantly correlated with the time to ChT removal (Spearman's ρ = 0.5865, P < 0.001). While the presence of pulmopleural fistulae following surgery did not result in significant intergroup differences (wedge, segment and lobe) in ChT removal, patients following wedge resection were released earlier from hospital (P = 0.0247) (Fig. 3C ).
DISCUSSION
We conducted this prospective clinical trial to highlight the variation in ChT management at specialized thoracic surgery units in Germany, and to assess its impact on postoperative length of stay.
The objective time to air leakage closure proved to be independent of the marked interdepartmental procedural differences, but these differences affected the time to tube removal in a significant way: The delay between air leakage closure and removal increased the duration of ChT therapy by a factor of nearly 2. Additionally, even though the length of postoperative hospital stay is significantly correlated to the duration of ChT therapy, the delay between tube removal and hospital discharge does not correlate with the duration of ChT therapy. This result promises opportunities to shorten the duration of hospital stay through improvements in two ways: (i) shortening the duration of ChT therapy by developing optimal strategies based on digital pump devices and (ii) reducing the delay between ChT removal and hospital discharge following a fast-track approach.
Our study has some limitations: the comparison of 79 patients treated in four independent specialist thoracic surgery units with varying postoperative ChT management protocols on one hand limits the significance of our findings, and on the other hand provides useful comparative-effectiveness evidence. This evidence, however, is specific to the German health care situation, but may be applicable to other European settings that unequivocally differ from the health care system of the USA, where most of the published evidence and recommendations on ChT therapy and fast-track approaches have been made.
The finding that higher suction (negative pressure) levels result in earlier air leakage closure did not reach statistical significance. This is probably due to the small case number in this study and warrants future investigations in larger study cohorts.
The detected delay periods between (i) air leakage closure and ChT removal and (ii) hospital discharge may be motivated by a certain level of uncertainty in the era of ChT assessment through traditional means. Although previous studies have shown that the reporting of digital pleural drainage systems is reliable and may afford earlier ChT removal, the traditional safety corridors still have to be overcome. The use of digital pleural drainage systems, however, will be particularly helpful in overcoming the first delay.
The finding of interest is that despite a relatively narrow duration of air leakage, there was a higher variation in the overall duration of ChT therapy. Therefore, this survey may launch a discussion on strategies to develop broadly accepted and applicable recommendations for postoperative ChT management in patients. Currently, a follow-up trial tests a standardized ChT protocol in a specified subgroup of patients (NCT01177215). Acknowledging the variety of disease patterns covered in thoracic surgery, different guidelines may be needed for diverse patient-subgroups.
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